Call Us: 1.800.873.5297


Transvaginal Mesh Lawsuit Status Update: Settlement Reached in Second Federal Trial Scheduled to Begin Against C.R. Bard

Bloomberg News reports that the second federal trial in the Multidistrict Litigation against C.R. Bard, In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation (MDL 2187), was scheduled to begin in West Virginia this week involving Ms. Wanda Queen from North Carolina who alleges that her transvaginal mesh device has caused her significant pain and injury, while forcing her to undergo six revision surgeries (Queen v. C.R. Bard Inc., Case No. 11-cv-00012). However, Judge Joseph R. Goodwin, the judge presiding over the case, has been notified that a settlement has been reached against C.R. Bard in relation to the injuries Ms. Queen suffered as a result of the transvaginal mesh device. Terms of the settlement were not disclosed. A Bard spokesperson said that the settlement in this individual case involving Ms. Wanda Queen was not part of a larger resolution of thousands of other C.R. Bard cases pending in the Multidistrict Litigation.

This settlement in the case of Ms. Wanda Queen comes a week after the first federal transvaginal mesh trial took place, where a West Virginia jury entered a verdict in favor of plaintiff Donna Cisson after a 12-day trial (Cisson v. C.R. Bard Inc., Case No. 2:11-cv-00195). In particular, the jury ordered Bard to pay $2 million in damages to plaintiff Donna Cisson after finding that a Bard Avaulta Plus device degraded her body, causing her pain and other physical ailments and requiring her to undergo several revision surgeries.

The results of the first two trials against C.R. Bard do not guarantee a favorable recovery or settlement for other cases currently pending against C.R. Bard or another transvaginal mesh manufacturer.

C.R. Bard faces thousands of other claims from women alleging that their transvaginal mesh device caused serious injuries. In particular, women across the nation have reported a number of serious complications stemming from these transvaginal mesh devices, such as device erosion, organ perforation, intense pain, inability to have sexual intercourse and infection. Many of these women have been required to undergo multiple revision surgeries.

According to the Judicial Panel on Multidistrict Litigation (JPML), there are six multidistrict litigations involving different transvaginal mesh device manufacturers where approximately 23,000 lawsuits are currently pending:

  • MDL 2187 – In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation: 4306 cases
  • MDL 2325 – In re: American Medical Systems, Pelvic Repair System Products Liability Litigation: 9263 cases
  • MDL 2326 – In re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation: 5546 cases
  • MDL 2327 – In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation: 9039 cases
  • MDL 2387 – In re: Coloplast Corp. Pelvic Support Systems Products Liability Litigation: 865 cases
  • MDL 2440 – In re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation: 72 cases

If you or a loved one has experienced serious injuries as a result of a transvaginal mesh device, contact one of our experienced attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297. We will confidentially evaluate your case for free and without any obligation.


Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases mentioned do not guarantee and/or predict outcomes in future cases.

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.